Wanbangde Pharmaceutical Holding Group Co Ltd (002082) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.04 Million ≈ $-151.51K USD) by net assets (CN¥2.77 Billion ≈ $404.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Wanbangde Pharmaceutical Holding Group C for the company's overall valuation and market capitalisation.
Wanbangde Pharmaceutical Holding Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wanbangde Pharmaceutical Holding Group Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Wanbangde Pharmaceutical Holding Group C to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Medplus Health Services Limited
NSE:MEDPLUS
|
0.159x |
|
Beijing Join-Cheer Software Co Ltd
SHE:002279
|
0.064x |
|
Fujian Boss Software Development Co Ltd
SHE:300525
|
0.016x |
|
CHINA RISUN GROUP HD-10
F:45Y
|
N/A |
|
Fujian Longxi Bearing Group Co Ltd
SHG:600592
|
0.011x |
|
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
|
0.071x |
|
Pet Valu Holdings Ltd
TO:PET
|
0.518x |
|
Zhongtong Bus Holding Co Ltd
SHE:000957
|
0.114x |
Annual Cash Flow Conversion Efficiency for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. View Wanbangde Pharmaceutical Holding Group C stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.61 Billion ≈ $381.57 Million |
CN¥603.98 Million ≈ $88.38 Million |
0.232x | +431.07% |
| 2024-12-31 | CN¥2.76 Billion ≈ $403.35 Million |
CN¥120.22 Million ≈ $17.59 Million |
0.044x | +265.13% |
| 2023-12-31 | CN¥2.76 Billion ≈ $403.72 Million |
CN¥-72.87 Million ≈ $-10.66 Million |
-0.026x | +68.93% |
| 2022-12-31 | CN¥2.82 Billion ≈ $412.52 Million |
CN¥-239.65 Million ≈ $-35.07 Million |
-0.085x | -1156.46% |
| 2021-12-31 | CN¥2.74 Billion ≈ $401.63 Million |
CN¥22.09 Million ≈ $3.23 Million |
0.008x | -84.77% |
| 2020-12-31 | CN¥2.86 Billion ≈ $418.23 Million |
CN¥151.01 Million ≈ $22.10 Million |
0.053x | +140.62% |
| 2019-12-31 | CN¥1.91 Billion ≈ $279.76 Million |
CN¥-248.69 Million ≈ $-36.39 Million |
-0.130x | -265.60% |
| 2018-12-31 | CN¥1.72 Billion ≈ $252.22 Million |
CN¥135.40 Million ≈ $19.81 Million |
0.079x | +815.48% |
| 2017-12-31 | CN¥1.60 Billion ≈ $234.64 Million |
CN¥-17.60 Million ≈ $-2.58 Million |
-0.011x | -104.93% |
| 2016-12-31 | CN¥1.40 Billion ≈ $204.36 Million |
CN¥310.71 Million ≈ $45.47 Million |
0.222x | +1687.76% |
| 2015-12-31 | CN¥1.35 Billion ≈ $197.11 Million |
CN¥16.76 Million ≈ $2.45 Million |
0.012x | -88.50% |
| 2014-12-31 | CN¥1.30 Billion ≈ $189.69 Million |
CN¥140.31 Million ≈ $20.53 Million |
0.108x | -45.14% |
| 2013-12-31 | CN¥1.19 Billion ≈ $173.83 Million |
CN¥234.35 Million ≈ $34.29 Million |
0.197x | +6.79% |
| 2012-12-31 | CN¥1.10 Billion ≈ $160.59 Million |
CN¥202.73 Million ≈ $29.67 Million |
0.185x | +13651.98% |
| 2011-12-31 | CN¥1.05 Billion ≈ $154.24 Million |
CN¥-1.44 Million ≈ $-210.26K |
-0.001x | -100.79% |
| 2010-12-31 | CN¥936.13 Million ≈ $136.98 Million |
CN¥162.26 Million ≈ $23.74 Million |
0.173x | +106.47% |
| 2009-12-31 | CN¥811.59 Million ≈ $118.76 Million |
CN¥68.13 Million ≈ $9.97 Million |
0.084x | -76.37% |
| 2008-12-31 | CN¥712.31 Million ≈ $104.23 Million |
CN¥253.06 Million ≈ $37.03 Million |
0.355x | +1084.23% |
| 2007-12-31 | CN¥415.12 Million ≈ $60.74 Million |
CN¥12.45 Million ≈ $1.82 Million |
0.030x | +206.57% |
| 2006-12-31 | CN¥357.72 Million ≈ $52.35 Million |
CN¥3.50 Million ≈ $512.24K |
0.010x | -86.67% |
| 2005-12-31 | CN¥152.88 Million ≈ $22.37 Million |
CN¥11.23 Million ≈ $1.64 Million |
0.073x | -69.41% |
| 2004-12-31 | CN¥136.17 Million ≈ $19.93 Million |
CN¥32.69 Million ≈ $4.78 Million |
0.240x | -36.09% |
| 2003-12-31 | CN¥98.53 Million ≈ $14.42 Million |
CN¥37.01 Million ≈ $5.42 Million |
0.376x | -- |
About Wanbangde Pharmaceutical Holding Group Co Ltd
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascul… Read more